Evaluating experiences of volunteers in an HIV vaccine trial will be useful for the conduct of future trials. The purpose of this study among volunteers who participated in a phase I/II HIV vaccine trial in Dar es Salaam, Tanzania was to assess what characterized their experiences during the trial. We conducted four focus group discussions with 35 out of the 60 individuals (women and men) after the five scheduled vaccinations. An interpretive description approach was applied to data analysis. As a result of the trial interventions, both men and women gained confidence in their own abilities to have safer, less risky sexual behaviour. The participants experienced the trial as a way of accessing free [insured] medical services. Most of the me...
Background: Eventual control of HIV/AIDS is believed to be ultimately dependent on a safe, effective...
Background: Research to discover an effective and safe vaccine is crucial to decrease HIV burden. Ho...
Abstract Background Results from HIV vaccine trials on potential volunteers will contribute to globa...
Background: Evaluating experiences of volunteers in an HIV vaccine trial will be useful for the cond...
Results from HIV vaccine trials on potential volunteers will contribute to global efforts to develop...
BACKGROUND:The development of an effective preventive HIV vaccine is the best-known option to halt i...
Background: Volunteers in phase I/II HIV vaccine trials are assumed to be at low risk of acquiring H...
BACKGROUND: Volunteers in phase I/II HIV vaccine trials are assumed to be at low risk of acquiring H...
Volunteers in phase I/II HIV vaccine trials are assumed to be at low risk of acquiring HIV infection...
Volunteers in phase I/II HIV vaccine trials are assumed to be at low risk of acquiring HIV infection...
Magister Public Health - MPHA qualitative descriptive study approach was used to gather the required...
Background: HIV vaccine efficacy trials require the active participation of volunteers who are ...
Background: As HIV infection continues to be a public health problem, development of an effective pr...
Background: Volunteers in phase I/II HIV vaccine trials are assumed to be at low risk of acquiring H...
Background: As HIV infection continues to devastate low-income countries, efforts to search for an e...
Background: Eventual control of HIV/AIDS is believed to be ultimately dependent on a safe, effective...
Background: Research to discover an effective and safe vaccine is crucial to decrease HIV burden. Ho...
Abstract Background Results from HIV vaccine trials on potential volunteers will contribute to globa...
Background: Evaluating experiences of volunteers in an HIV vaccine trial will be useful for the cond...
Results from HIV vaccine trials on potential volunteers will contribute to global efforts to develop...
BACKGROUND:The development of an effective preventive HIV vaccine is the best-known option to halt i...
Background: Volunteers in phase I/II HIV vaccine trials are assumed to be at low risk of acquiring H...
BACKGROUND: Volunteers in phase I/II HIV vaccine trials are assumed to be at low risk of acquiring H...
Volunteers in phase I/II HIV vaccine trials are assumed to be at low risk of acquiring HIV infection...
Volunteers in phase I/II HIV vaccine trials are assumed to be at low risk of acquiring HIV infection...
Magister Public Health - MPHA qualitative descriptive study approach was used to gather the required...
Background: HIV vaccine efficacy trials require the active participation of volunteers who are ...
Background: As HIV infection continues to be a public health problem, development of an effective pr...
Background: Volunteers in phase I/II HIV vaccine trials are assumed to be at low risk of acquiring H...
Background: As HIV infection continues to devastate low-income countries, efforts to search for an e...
Background: Eventual control of HIV/AIDS is believed to be ultimately dependent on a safe, effective...
Background: Research to discover an effective and safe vaccine is crucial to decrease HIV burden. Ho...
Abstract Background Results from HIV vaccine trials on potential volunteers will contribute to globa...